Boundless Bio, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q4 2022 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary: Boundless Bio, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2022 to Q2 2024.
Boundless Bio, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending June 30, 2024 was $179M.

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$179M	+$283M		Jun 30, 2024	10-Q	2024-08-12
Q1 2024	-$141M	-$48.7M	-52.7%	Mar 31, 2024	10-Q	2024-08-12
Q4 2023	-$127M	-$45.4M	-55.6%	Dec 31, 2023	10-Q	2024-08-12
Q2 2023	-$104M			Jun 30, 2023	10-Q	2024-08-12
Q1 2023	-$92.4M			Mar 31, 2023	10-Q	2024-08-12
Q4 2022	-$81.7M			Dec 31, 2022	10-Q	2024-08-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.